Phase Ib Clinical Study of Keynatinib

Clinical trial NCT04807881 · RECRUITING

Trial details

NCT number: NCT04807881
Sponsor: Medolution Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, B-Cell

Start date: 2020-09-24
Primary completion: 2027-10-10
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.